Navigation Links
Micromet, Inc. Reports First Quarter 2009 Financial Results
Date:5/6/2009

or development expenses incurred in this collaboration.

  • On January 13, Micromet together with the Ludwig-Maximilian-University in Munich, Germany published data in the peer reviewed journal Nature Cell Biology revealing a novel signaling function of the epithelial cell adhesion molecule, or EpCAM, which is expressed at high frequency on many tumor types. The data indicate that only cancer cells have an active signaling form of EpCAM that promotes tumor formation. This data further supports the scientific and clinical rationale behind two of Micromet's most advanced clinical product candidates, adecatumumab and MT110, both of which target EpCAM.

  • On February 23, Micromet announced the addition of Kapil Dhingra, M.D. to the Board of Directors. Dr. Dhingra has been active in oncology clinical research for over 20 years, most recently as head of Oncology Development at Hoffman La-Roche, where he built the largest oncology clinical development department in the industry. Dr. Dhingra brings deep oncology development experience and perspective to Micromet's Board of Directors.

  • On March 12, Micromet announced that it had regained North American rights to its most advanced product candidate, blinatumomab (MT103), from MedImmune. Micromet is responsible for the further clinical development and commercialization of blinatumomab. MedImmune is obligated to complete the development of the commercial scale manufacturing process for blinatumomab at its cost. Upon the first marketing approval of blinatumomab in the United States, MedImmune will have a one-time option to reacquire the commercialization rights in North America at pre-defined terms.

  • On March 23, Micromet announced the initiation of a new pha
    '/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Micromet, Inc. Reports First Quarter 2008 Financial Results
2. Micromet, Inc. Reports Second Quarter 2008 Financial Results
3. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annual Meeting
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Haemacure Reports Third Quarter 2007 Results
6. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. MDS Reports Third Quarter 2007 Results
9. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... (PRWEB) May 27, 2015 Get ... dedicated to ending the spread of HIV, will recognize ... the 1st Annual YesGTCV Social Ambassador Awards, to be ... 7 p.m. PST. , A first for public health ... Coachella Valley’s most active online influencers for breaking down ...
(Date:5/27/2015)... Ca (PRWEB) May 27, 2015 According ... of Texas Southwestern Medical Center at Dallas some migraine ... syndrome. Both CTS and migraine headache apparently also have ... in incidents of obesity, people with a history of ... less common in Asians, and CTS in particular was ...
(Date:5/27/2015)... The Advanced Fertility Center of Chicago announces that their ... better serve the needs of couples in Chicagoland. The ... Northwest side of the city at 4920 North Central Ave., ... the Chicago office at (773) 794–1818. This is the ... The other 2 offices are in Gurnee and Crystal ...
(Date:5/26/2015)... Missouri (PRWEB) May 27, 2015 ... recently filed testosterone gel lawsuit . The suit ... AbbVie. The suit was filed in late April 2015, ... filed in an Illinois federal court in mid-May.¹ , ... District Court for the Northern District of Illinois. The ...
(Date:5/26/2015)... 27, 2015 Securityhunter has ... by the United States Department of Health and Human ... The MATOC was awarded through the General Services ... for the PSC, which is a fee-for-service agency. The ... year options, and is an enterprise–wide physical security and ...
Breaking Medicine News(10 mins):Health News:Regional Public Health Campaign to Host 1st Annual YesGTCV Social Ambassador Awards 2Health News:Regional Public Health Campaign to Host 1st Annual YesGTCV Social Ambassador Awards 3Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 2Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 3Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 4Health News:The Advanced Fertility Center of Chicago Opens a New Fertility Office Location in Chicago 2Health News:Carey Danis & Lowe Comments on Recently Filed Testosterone Gel Lawsuit 2Health News:Securityhunter Has Been Awarded a Multiple Award Task Order Contract (MATOC) by the Department of Health and Human Services 2
... State ... Medical Center ... Clinical Trial TUSTIN, Calif. and SYDNEY, April 22 ... heart assist technologies, announced today that The Ohio State University Medical ...
... Parks to hold second annual Walk-a-thon event THIS SUMMERNEW YORK, ... Six Flags, and Cure Kids Cancer have teamed up once ... its "A Walk In The Park" program. This unique ... properties April 26 through July 26 offering local neighborhoods a ...
... Smokefree Laws, Three plus DC Raised Tobacco Taxes--WASHINGTON, April 22 ... Lung Association, 2008 proved to be a slow year for ... select few taking the steps that are needed to curb ... update of State Legislated Actions on Tobacco Issues ...
... BILTHOVEN and NIJMEGEN, The Netherlands, April 22 ... Medical Centre have entered,into a research agreement ... , Under the ... Experimental Urology), InteRNA,s unique lentiviral-based miRNA,overexpression library ...
... a week, , , WEDNESDAY, April 22 (HealthDay News) -- Men ... to have a reduced risk of heart failure, a new ... Swedish researchers followed nearly 40,000 Swedish men, ages 45 to ... outcomes. During that time, 597 men with no history of ...
... Together to Ask President Obama for a Greater Voice in the ... ... April 22, 2009 -- In recent days, both conservative and liberal ... in the healthcare reform debate. Understanding that President Obama has ...
Cached Medicine News:Health News:Video: U.S. Announcement - First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 2Health News:Video: U.S. Announcement - First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 3Health News:Video: U.S. Announcement - First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 4Health News:Six Flags Friends Invites Guests to Help Cure Kids Cancer by Taking 'A Walk In The Park' 2Health News:Six Flags Friends Invites Guests to Help Cure Kids Cancer by Taking 'A Walk In The Park' 3Health News:Six Flags Friends Invites Guests to Help Cure Kids Cancer by Taking 'A Walk In The Park' 4Health News:New American Lung Association Report Reveals States Failing to Enact Lifesaving Tobacco Control Policies 2Health News:New American Lung Association Report Reveals States Failing to Enact Lifesaving Tobacco Control Policies 3Health News:InteRNA Technologies and Radboud University Nijmegen Medical Centre to Develop microRNA-based Therapeutics for Prostate Cancer 2Health News:Fatty Fish May Cut Heart Failure Risk in Men 2Health News:Millennials Push For Seat at the Table on Healthcare Reform 2
(Date:5/26/2015)... , May 26, 2015  AbbVie (NYSE: ... Phase 3 GIFT-I study of its investigational, all-oral, ... treatment with ombitasvir/paritaprevir/ritonavir at the Annual Meeting of ... Japan . 1 GIFT-I evaluated ... infected Japanese patients, with and without cirrhosis, who ...
(Date:5/26/2015)... -- XRpro Sciences, Inc., a provider of a unique platform for ... and ion channel assays for the pharmaceutical industry, announced today ... MicroCap Conference on Thursday, May 28, 2015 in ... Hotel. The Company,s presentation by Richie Cunningham ... to begin at 1:30 p.m ET. Click here to view ...
(Date:5/26/2015)... , England and PITTSBURGH , May 26, ... leading global pharmaceutical company, today announced that Mylan CEO ... Bernstein Strategic Decisions Conference, Friday, May 29, 2015 at ... access a live webcast of the presentation via the ... . An archived version will also be available following ...
Breaking Medicine Technology:AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 3AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 4AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 5AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 6XRpro Sciences, Inc. To Present at 2015 Marcum MicroCap Conference 2
... Families of Spinal Muscular Atrophy announced today that Repligen ... Administration to commence a Phase I safety study in healthy ... for Spinal Muscular Atrophy. FSMA began the ... drug development, when risk is the highest.  It was the ...
... BD (Becton, Dickinson and Company) (NYSE: ... today the publication of its 2010 Sustainability Report ... dedicated associates worldwide to pursuing the Company,s purpose, " ... so in a way that is centered on balancing ...
Cached Medicine Technology:Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA 2Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA 3BD Issues 2010 Sustainability Report 2BD Issues 2010 Sustainability Report 3
... The High Throughput Sorter RSD ... high volume laboratories in the field ... is not only of considerable speed ... optional Recapping Module can be integrated. ...
... System RCS 800 closes various plastic primary and ... way. Different tube heights and diameters can be ... be used for send-outs. The integration into other ... System RSD 800 and High Throughput Sorter RSD ...
... Decapping System DS 800 selectively removes closures from ... the barcode towards the rack opening in one ... integrated in PVT Systems like Sorting System RS ... Sorter RSD ProVolume and Aliquoting System RSD 800A. ...
... Nanogen offers reagents to detect sequences ... parainfluenza virus 1, 2 and 3; ... respiratory syncytial virus A and B. ... to create homebrew tests., ...
Medicine Products: